Source: ERJ Open Res, 5 (4) 00223-2018; 10.1183/23120541.00223-2018
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Zachary Boivin, Mario F. Perez, Nkiruka C. Atuegwu, Mark Metersky, Carlos A. Alvarez, Antonio Anzueto, Eric M. Mortensen. Association of atypical antipsychotics and mortality for patients hospitalised with pneumonia. ERJ Open Res, 5 (4) 00223-2018; 10.1183/23120541.00223-2018

Member's Comments

No comment yet.

Related content which might interest you: Association of doxycycline and mortality in patients hospitalized with pneumonia Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020 Association of metformin and mortality for patients with diabetes who are hospitalized with pneumonia Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 Obesity and outcomes in patients hospitalized for pneumonia Source: Annual Congress 2012 - Prognosis and outcome of respiratory infections Year: 2012 Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Prior use of both a statin and ARB is associated with lower mortality for patients hospitalized with pneumonia Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016 Clinical features of COVID-19 pneumonia in elderly patients Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009 Clinical features associated with mortality in patients with community acquired pneumonia requiring hospitalisation Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004 Risk contribution of comorbidities in hospitalized patients with Covid 19 pneumonia Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients Source: Eur Respir J 2015; 45: 463-472 Year: 2015 Out-patient combination therapy with inhaled corticosteroids and bronchodilators is associated with lower in-hospital mortality in pneumonia in patient with COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Association of dyspnoea, mortality and resource use in hospitalised patients Source: Eur Respir J, 58 (3) 1902107; 10.1183/13993003.02107-2019 Year: 2021 Differential clinical and etiological features in young and elderly patients hospitalized due to community-acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002 Impact of obesity on outcomes for patients hospitalised with pneumonia Source: Eur Respir J 2013; 41: 929-934 Year: 2013 Validity of the diagnosis of pneumonia in hospitalised patients with COPD Source: ERJ Open Res, 5 (2) 00031-2019; 10.1183/23120541.00031-2019 Year: 2019 Risk of pneumonia or death in COPD outpatients treated with different lengths of corticosteroids Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 Criteria for clinical stability in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2013; 42: 742-749 Year: 2013 Timing of previous hospitalizations impacts outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Does previous warfarin treatment effect complications and outcome in hospitalised patients with community-acquired pneumonia? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 COPD medications and risk of pneumonia in the UK Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects Year: 2008